David Tung

621 total citations
22 papers, 501 citations indexed

About

David Tung is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Tung has authored 22 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Tung's work include Immune Response and Inflammation (4 papers), Cell Adhesion Molecules Research (4 papers) and Asthma and respiratory diseases (3 papers). David Tung is often cited by papers focused on Immune Response and Inflammation (4 papers), Cell Adhesion Molecules Research (4 papers) and Asthma and respiratory diseases (3 papers). David Tung collaborates with scholars based in United States, Switzerland and United Kingdom. David Tung's co-authors include Peter A. Ward, Saurabh Saha, Ralph C. Schimmer, Craig M. Flory, Denis J. Schrier, Michael M. Morgen, Mausumee Guha, Susan A. Gregory, Anne‐Marie Malfait and Jeffrey R. Crosby and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David Tung

22 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Tung United States 13 129 117 91 84 72 22 501
Shoichiro Yano Japan 14 177 1.4× 177 1.5× 34 0.4× 56 0.7× 82 1.1× 18 688
Peadar Rooney Ireland 11 161 1.2× 108 0.9× 119 1.3× 62 0.7× 40 0.6× 18 599
Ken Shiraishi Japan 16 185 1.4× 186 1.6× 52 0.6× 25 0.3× 63 0.9× 57 658
A. Khemis France 16 84 0.7× 360 3.1× 52 0.6× 93 1.1× 77 1.1× 35 1.0k
Michiyuki Koga Japan 14 135 1.0× 241 2.1× 81 0.9× 23 0.3× 73 1.0× 41 750
Holger Schrumpf Germany 16 212 1.6× 127 1.1× 104 1.1× 51 0.6× 155 2.2× 30 1.2k
Ch.C. Zouboulis Germany 24 315 2.4× 121 1.0× 171 1.9× 131 1.6× 136 1.9× 41 1.4k
Hsi‐Ming Lee United States 8 94 0.7× 70 0.6× 41 0.5× 34 0.4× 89 1.2× 10 868
Rafaela Vaz Sousa Pereira Brazil 13 151 1.2× 99 0.8× 66 0.7× 24 0.3× 73 1.0× 27 562
Deepak Venkatesh India 13 403 3.1× 184 1.6× 40 0.4× 44 0.5× 58 0.8× 18 852

Countries citing papers authored by David Tung

Since Specialization
Citations

This map shows the geographic impact of David Tung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tung more than expected).

Fields of papers citing papers by David Tung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tung. The network helps show where David Tung may publish in the future.

Co-authorship network of co-authors of David Tung

This figure shows the co-authorship network connecting the top 25 collaborators of David Tung. A scholar is included among the top collaborators of David Tung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tung. David Tung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nelson, Blessie Elizabeth, Siqing Fu, David S. Hong, et al.. (2023). Abstract CT107: Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. Cancer Research. 83(8_Supplement). CT107–CT107. 16 indexed citations
2.
Tung, David, et al.. (2014). Colchicine overdose with coingestion of nonsteroidal antiinflammatory drugs. Canadian Journal of Emergency Medicine. 16(3). 252–256. 5 indexed citations
3.
Tung, David, et al.. (2013). Possible Therapeutic Effect of Trilostane in Rodent Models of Inflammation and Nociception. Current Therapeutic Research. 75. 71–76. 2 indexed citations
4.
Tung, David, et al.. (2012). Differential Effects of Cyclosporin and Etanercept Treatment on Various Pathologic Parameters in a Murine Model of Irradiation-Induced Mucositis. Current Therapeutic Research. 73(4-5). 150–164. 4 indexed citations
5.
Morgen, Michael M., et al.. (2012). Nanoparticles for Improved Local Retention after Intra-Articular Injection into the Knee Joint. Pharmaceutical Research. 30(1). 257–268. 73 indexed citations
6.
Tung, David, et al.. (2012). Novel Anti-Inflammatory Effects of Doxazosin in Rodent Models of Inflammation. Pharmacology. 91(1-2). 29–34. 12 indexed citations
7.
Tung, David, et al.. (2011). In Vivo Effects of Immunomodulators in a Murine Model of Fluorouracil-Induced Mucositis. Current Therapeutic Research. 72(6). 262–272. 24 indexed citations
8.
Tung, David, et al.. (2011). Novel Anti-Inflammatory Effects of Repaglinide in Rodent Models of Inflammation. Pharmacology. 88(5-6). 295–301. 8 indexed citations
9.
Tung, David, et al.. (2011). Anti-Inflammatory and Immunomodulatory Effects of Bortezomib in Various in vivo Models. Pharmacology. 88(1-2). 100–113. 17 indexed citations
10.
Nemirovskiy, Olga V., David Tung, Adam Skepner, et al.. (2010). Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis. Xenobiotica. 40(8). 586–592. 10 indexed citations
11.
Prévot, Anne, et al.. (2009). Beneficial effect of insulin-like growth factor-1 on hypoxemic renal dysfunction in the newborn rabbit. Pediatric Nephrology. 24(5). 973–981. 2 indexed citations
12.
Chiang, Po‐Chang, et al.. (2009). Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery. Nanoscale Research Letters. 4(3). 254–261. 43 indexed citations
13.
Chiang, Po‐Chang, et al.. (2009). Euthanasia method for mice in rapid time-course pulmonary pharmacokinetic studies.. PubMed. 48(5). 506–11. 22 indexed citations
14.
Crosby, Jeffrey R., Mausumee Guha, David Tung, et al.. (2007). Inhaled CD86 Antisense Oligonucleotide Suppresses Pulmonary Inflammation and Airway Hyper-Responsiveness in Allergic Mice. Journal of Pharmacology and Experimental Therapeutics. 321(3). 938–946. 34 indexed citations
15.
Karras, James G., Jeffrey R. Crosby, Mausumee Guha, et al.. (2006). Anti-Inflammatory Activity of Inhaled IL-4 Receptor-α Antisense Oligonucleotide in Mice. American Journal of Respiratory Cell and Molecular Biology. 36(3). 276–285. 81 indexed citations
16.
Fong, Keng Leong, et al.. (2005). A Complete Dual-band Chip-set with USB 2.0 Interface for IEEE 802.11 a/b/g WLAN applications. 257–260. 1 indexed citations
17.
Schimmer, Ralph C., Denis J. Schrier, Craig M. Flory, et al.. (1998). Streptococcal Cell Wall-Induced Arthritis: Requirements for IL-4, IL-10, IFN-γ, and Monocyte Chemoattractant Protein-1. The Journal of Immunology. 160(3). 1466–1471. 18 indexed citations
18.
Schimmer, Ralph C., Denis J. Schrier, Craig M. Flory, et al.. (1998). Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1.. PubMed. 160(3). 1466–71. 22 indexed citations
19.
Tung, David, Lars M. Bjursten, Benjamin W. Zweifach, & Geert W. Schmid‐Schönbein. (1997). Leukocyte contribution to parenchymal cell death in an experimental model of inflammation. Journal of Leukocyte Biology. 62(2). 163–175. 12 indexed citations
20.
Iranpour, R. & David Tung. (1989). Methodology for Optimal Design of a Parking Lot. Journal of Transportation Engineering. 115(2). 139–160. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026